Singapore
· Delayed Price · Currency is SGD Clearbridge Health Statistics
Total Valuation
Clearbridge Health has a market cap or net worth of SGD 4.96 million. The enterprise value is 11.28 million.
| Market Cap | 4.96M |
| Enterprise Value | 11.28M |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Clearbridge Health has 619.74 million shares outstanding. The number of shares has increased by 0.13% in one year.
| Shares Outstanding | 619.74M |
| Shares Change (YoY) | +0.13% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 35.54% |
| Owned by Institutions (%) | 1.92% |
| Float | 339.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.48 |
| PB Ratio | 0.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.34 |
| EV / Sales | 1.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.87 |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.67.
| Current Ratio | 1.13 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.72 |
| Interest Coverage | -7.22 |
Financial Efficiency
Return on equity (ROE) is -124.20% and return on invested capital (ROIC) is -9.55%.
| Return on Equity (ROE) | -124.20% |
| Return on Assets (ROA) | -8.63% |
| Return on Capital (ROIC) | -9.55% |
| Revenue Per Employee | 86,083 |
| Profits Per Employee | -272,711 |
| Employee Count | 121 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 19.94 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -55.56% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 44.17 |
| Average Volume (20 Days) | 1,052,945 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Clearbridge Health had revenue of SGD 10.42 million and -33.00 million in losses. Loss per share was -0.05.
| Revenue | 10.42M |
| Gross Profit | 5.06M |
| Operating Income | -5.19M |
| Pretax Income | -35.56M |
| Net Income | -33.00M |
| EBITDA | -4.88M |
| EBIT | -5.19M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 2.25 million in cash and 6.75 million in debt, giving a net cash position of -4.50 million or -0.01 per share.
| Cash & Cash Equivalents | 2.25M |
| Total Debt | 6.75M |
| Net Cash | -4.50M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 10.13M |
| Book Value Per Share | 0.01 |
| Working Capital | 558,000 |
Cash Flow
In the last 12 months, operating cash flow was -3.49 million and capital expenditures -443,000, giving a free cash flow of -3.94 million.
| Operating Cash Flow | -3.49M |
| Capital Expenditures | -443,000 |
| Free Cash Flow | -3.94M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 48.61% |
| Operating Margin | -49.80% |
| Pretax Margin | -341.42% |
| Profit Margin | n/a |
| EBITDA Margin | -46.84% |
| EBIT Margin | -49.80% |
| FCF Margin | -37.80% |
Dividends & Yields
Clearbridge Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.13% |
| Shareholder Yield | -0.13% |
| Earnings Yield | -666.16% |
| FCF Yield | -79.41% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Clearbridge Health has an Altman Z-Score of -5.96. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.96 |
| Piotroski F-Score | n/a |